Sort   by:  
 Page size 
UnknownDistinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology.
Not available
S-EPMC11095424 | biostudies-literature
UnknownExploring sex-specific risk factors in cognitive decline: Insights into modifiable and non-modifiable determinants using a network analysis.
Not available
S-EPMC12639403 | biostudies-literature
UnknownRasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders.
Not available
S-EPMC10273843 | biostudies-literature
UnknownPerivascular spaces, plasma GFAP, and speeded executive function in neurodegenerative diseases.
Not available
S-EPMC11350014 | biostudies-literature
UnknownSoluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in Stroke.
Not available
S-EPMC9973594 | biostudies-literature
UnknownCommon Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain Disorders.
Not available
S-EPMC8859302 | biostudies-literature
UnknownAssociation of Dual-Task Gait Cost and White Matter Hyperintensity Burden Poststroke: Results From the ONDRI.
Not available
S-EPMC10350733 | biostudies-literature
UnknownAssociation of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative.
Not available
S-EPMC10984487 | biostudies-literature
UnknownTwo Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Not available
S-EPMC10794000 | biostudies-literature
Sort   by:  
 Page size